Category Archives: Uncategorized

Risky Business

The author of The 10b-5 Daily (Lyle Roberts) has co-written an article on Law360 about the use of risk disclosures as alleged misstatements in securities class actions. The article discusses the current circuit split on the issue, the Supreme Court’s decision to drop the Facebook case, the pending Adidas case, and where this all may be headed.

The article can be found here: https://www.law360.com/articles/2361203/gauging-the-risky-business-of-business-risk-disclosures

Leave a comment

Filed under All The News That's Fit To Blog, Uncategorized

Looks Prehistoric

An ongoing issue in securities litigation is to what extent a short seller’s report can act as a corrective disclosure for purposes of establishing loss causation.  The U.S. Court of Appeals for the Fourth Circuit had the opportunity to address that issue for the first time last week.

In Defeo v. IonQ, Inc., 2025 WL 1035292 (4th Cir. April, 8, 2025), the plaintiffs alleged that a short seller report had revealed to investors that IonQ, which makes quantum computing systems, did not have a working product and its revenues were driven by phony related-party transactions.  The company responded to the report with a short press release deriding the report’s inaccuracies and then later issued a longer rebuttal.  The company’s stock price declined during this period.

The district court held that the plaintiffs’ complaint did not contain any reliable sources and therefore failed to adequately plead the elements of a federal securities claim.  In addressing a subsequent amended complaint, however, the district court found that the amendment was futile solely on the basis that the plaintiffs could not adequately plead loss causation.

On appeal, the Fourth Circuit only addressed the issue of loss causation.  As to the short seller report, the court noted that while short seller reports could potentially act as corrective disclosures, in this instance the report “relies on anonymous sources for its nonpublic information and disclaims its accuracy.”  Indeed, as to the report’s use of sources, the publisher stated that some quotations “may be paraphrased, truncated, and/or summarized solely at our discretion, and do not always represent a precise transcript of those conversations.”  Under these circumstances, the Fourth Circuit concluded that the “potential evidentiary value [of the report] evaporates” and it could not form the basis for loss causation.

Alternatively, the plaintiffs argued that the company’s initial response to the short seller report, which did not provide a point-by-point rebuttal, revealed to investors that the report was to some extent accurate.  The Fourth Circuit noted it could “envision a scenario where a third party exposes some unverified bombshell about a company and the company’s tacit mea culpa could function as a verification of that bombshell” but that this “theory holds no water here.”  The company’s press release generally rejected the report’s allegations.

Holding: Judgment of the district court finding amendment futile affirmed.

Quote of note: “The Report’s publisher admits some quotations ‘may be paraphrased, truncated, and/or summarized solely at our discretion, and do not always represent a precise transcript of those conversations.’ That disclosure is particularly troubling because it gives Scorpion Capital the kind of editorial license that could allow it to say just about anything and cloak it in the imprimatur of truth in order to make a buck. For example: If an expert represented, ‘IonQ’s 32-qubit system is revolutionary. By comparison, Company Y’s system looks prehistoric,’ Scorpion Capital gave itself the freedom to say, ‘IonQ’s 32-qubit system looks prehistoric,’ and attribute that quote to an expert. In all, those disclosures lead to the conclusion that ‘the character of the’ Report ‘rendered it inadequate’ to reveal any alleged truth to the market.”

Leave a comment

Filed under Appellate Monitor, Uncategorized

A Risky Campaign

Last year, the U.S. Supreme Court had the opportunity in the Facebook case to address the extent to which corporate risk disclosures can form the basis for securities fraud liability.  After oral argument, however, the Court decided to dismiss the appeal as improvidently granted.  That has left the door open for a wide range of potential decisions from the lower courts.

In Craig v. Target Corp., 2024 WL 4979234 (M.D. Fla. Dec. 4, 2024), the court considered whether Target’s risk disclosures in its 2021 and 2022 annual reports about ESG and DEI initiatives were false and misleading because they failed to disclose that the company would embark on a Pride Month Campaign in May 2023 that could result in customer boycotts and loss of sales. Target generally had disclosed that negative reputational incidents could adversely affect its results and that it faced varied stakeholder expectations regarding how it addressed environmental, social, and governance matters.  In addition, Target previously had been the subject of a customer boycott as the result of its opposition to North Carolina’s 2016 transgender bathroom law. 

The court found, however, that Target had failed “to mention the specific risk of its upcoming 2023 Pride Month Campaign” and that the company knew or should have known that this particular campaign “posed a risk of backlash and financial repercussions.”

Holding: Motion to dismiss denied.

Quote of note: “Target’s plan to enact a new campaign – i.e., placing controversial merchandise at the center of its stores – could be construed as a change to their ESG/DEI campaigns in prior years.  Upon review of the amended complaint and the parties’ briefing, it is unclear whether this information was publicly available and it is further unclear how much information investors and Plaintiffs knew about the plans for the new campaign.  Thus, Plaintiffs have adequately pleaded that information revealed in the 2021 and 2022 risk disclosures may not have been complete.”

Leave a comment

Filed under Motion To Dismiss Monitor, Uncategorized

Compare and Contrast

NERA Economic Consulting and Cornerstone Research have released their respective 2024 annual reports on federal securities class action filings.  As usual, the different methodologies employed by the two organizations have led to slightly different numbers, although they both identify the same general trends.

The findings for 2024 include:

  1. The reports agree that overall filings have stayed steady. NERA finds that there were 229 filings (matching the number of filings in 2023), while Cornerstone finds that there were 225 filings (compared with 215 filings in 2023). Filings involving only Section 10(b)/Rule 10b-5 claims for securities fraud are an increasing percentage of the overall filings. Cornerstone found that 198 of the 225 filings fit this description, the highest level on record.  Relatedly, Cornerstone found that the number of federal and state 1933 Act filings decreased from 64 filings in 2022 to 32 filings in 2023 to 21 filings in 2024.
  1. NERA found that filings against companies in the technology and healthcare sectors combined accounted for more than half of all filings, and the Second and Ninth Circuits accounted for 61% of filings (excluding merger objections and crypto unregistered securities cases).
  1. Both reports agree that filings involving artificial intelligence (AI) claims are the fastest growing category. NERA and Cornerstone found that filings with AI-related claims more than doubled from 2023 to 2024 (NERA – 13 filings, Cornerstone – 15 filings).
  1. NERA found that after excluding cases involving merger objections, crypto unregistered securities, or settlements of $0 to the class, around 42% of settlements had a recovery of less than $10 million, another 40% had a settlement between $10 million and $49.9 million, and 18% settled for $50 million or more, largely mirroring the distribution of settlement values from 2023. The average settlement value in 2024 was $43 million, a roughly 7% decline relative to the 2023 inflation-adjusted average settlement value of $46 million.

The NERA report can be found here. The Cornerstone report can be found here.

Leave a comment

Filed under Lies, Damn Lies, And Statistics, Uncategorized

A Substantial Treat

In Macquarie, a recent decision from the U.S. Supreme Court, the Court addressed “half truth” liability for securities fraud.  Among other things, the Court noted that “the difference between an omission and a half-truth is the difference between a child not telling his parents he ate a whole cake and telling them he had dessert.  Rule 10b-5(b) does not proscribe pure omissions. . . . Put differently, it requires disclosure of information necessary to ensure that that statements already made are clear and complete (i.e., that the dessert was, in fact, a whole cake.)”  But how does this analogy work in the context of alleged material omissions in a company’s risk disclosures, which by their nature are talking about a dessert that has yet to be eaten (and may never be eaten)?

In Roofers Local N. 149 Pension Fund v. Amgen, Inc. 2024 WL 4358409 (S.D.N.Y. Sept. 30, 2024), the court considered a case involving Amgen’s risk disclosures surrounding its ongoing dispute with the IRS over back taxes.  The risk disclosures stated that the IRS’s proposed adjustments were “significant,” “substantial,” “may result in payments substantially greater than amounts accrued,” and “could have a material impact” on Amgen’s financial statements.  Amgen also disclosed that it did not agree with the adjustments and was contesting them.  What Amgen did not tell the market, however, was that the IRS had indicated to the company that it was seeking a total of $10.7 billion in back taxes.  When Amgen eventually disclosed the exact amounts that the IRS was seeking after receiving notices of deficiency, its stock price declined.  

As recognized in the Amgen decision, companies frequently decline to quantify the risks they face, instead using words like “significant” until the magnitude of the risks becomes more certain.  Nevertheless, the court found that the failure to disclose the $10.7 billion amount rendered Amgen’s risk disclosures materially misleading because investors were “left in the dark” about the magnitude of the potential liability.  While Amgen was “free to vigorously dispute the legal and factual merits of the IRS’s assessments, and to tell investors that it is doing so; what it cannot do consistent with Section 10(b) and Rule 10b-5, however, is present investors with an incomplete, unclear, and thus plausibly misleading picture of the financial risks posed by that dispute.”  Referring to the “whole cake” analogy used in Macquarie, the court noted that it did “not believe that the analogy would have come out differently had the child described his treat as merely ‘significant’ or ‘substantial’ instead.”

Holding: Motion to dismiss denied.

Leave a comment

Filed under Motion To Dismiss Monitor, Uncategorized

Compare And Contrast – Midyear 2024

The 10b-5 Daily is catching up on posts after a very busy August and September, so thanks everyone for your patience. NERA Economic Consulting and Cornerstone Research released their 20224 midyear reports on securities class action filings in August.  While the different methodologies employed by the two organizations usually lead to slightly different numbers, they managed mostly to match for this report.

The key findings include:

(1) The reports agree that filings are at steady levels as compared to 2023, with only a handful of merger objection cases.  Both NERA and Cornerstone find that there were 112 filings in the first half of 2024 (up slightly from the second half of 2023).

(2) The categories of filings that both reports identify as potential growth areas for the year are COVID-19 (7-8 filings) and artificial intelligence (6 filings). In contrast, SPAC, cryptocurrency, and cybersecurity filings are down relative to past years.

(3) Both reports find that the annual number of filings against foreign companies is on track to be the lowest in the last ten years, even while the percentage of U.S. listings by foreign companies has steadily increased. For example, Cornerstone finds that foreign companies currently make up 24.7% of U.S. listings, but have only been the subject of 14.2% of the filings in the first half of 2024.

(4) NERA finds that there were 100 cases resolved in the first half of 2024, if which 52 were dismissed and 48 were settled.

The NERA report can be found here and the Cornerstone report can be found here.

Leave a comment

Filed under Lies, Damn Lies, And Statistics, Uncategorized

Joining The Club

In Kolominsky v. Root, Inc., 2024 WL 1854474 (6th Cir. April 29, 2024), the plaintiffs brought claims under Section 10(b) of the Exchange Act (securities fraud) and Sections 11 and 12(a)(2) of the Securities Act (misstatements in registration statements and offerings) related to alleged misstatements about the company’s purportedly low customer-acquisition cost. The district court dismissed the claims based on the plaintiffs’ failure to adequately plead falsity. On appeal, the Sixth Circuit joined the majority of other circuits on two important issues related to Securities Act claims.

“Sounds in fraud” – Section 11 and 12(a)(2) claims do not have fraud as an element, so generally they are not subject to the heightened pleading standard of Federal Rule of Civil Procedure 9(b). When plaintiffs bring both Section 10(b) and Section 11 and 12(a)(2) claims in the same complaint, however, many courts have found that all of the claims “sound in fraud” and uniformly must be pled with particularity. In Kolominsky, the Sixth Circuit agreed that if the claims are “grounded in one fraudulent course of conduct relying on one set of facts” then Rule 9(b) applies.

“Bespeaks caution doctrine” – The bespeaks caution doctrine addresses situations where optimistic projections are coupled with cautionary language that impacts whether the statements are material or could reasonably have been relied upon by investors. The Private Securities Litigation Reform Act (PSLRA) has a safe harbor for forward-looking statements that applies to Securities Act claims, but there is an exclusion for statements made in connection with initial public offerings. In Kolominsky, the court held that the bespeaks caution doctrine has survived the codification of the PSLRA and joined its “sister circuits that hold when companies such as Root make forward-looking statements contained in a registration statement or in connection with an initial public offering, the Bespeaks Caution doctrine will shield those companies from liability when the forward-looking statements are accompanied by meaningful cautionary language so that a reasonable investor would understand the statements.”

Holding: Motion to dismiss affirmed.

Leave a comment

Filed under Appellate Monitor, Uncategorized

He Ate a Whole Cake

The U.S. Supreme Court has issued a decision in Macquarie Infrastructure Corp. v. Moab Partners, L.P. holding that the failure to disclose information required by Item 303 of Regulation S-K can support a Rule 10b-5(b) claim only if the omission renders affirmative statements misleading.  It is a unanimous decision authored by Justice Sotomayor.

Item 303 of Regulation S-K requires companies to describe “known trends or uncertainties” that may have a material impact on the company’s operations.  There has been a circuit split over whether a company’s failure to meet its Item 303 disclosure requirement can support a private claim under Section 10(b) and Rule 10b-5(b) in the absence of an otherwise-misleading statement.  The Second Circuit has held that a private claim can be brought based on this omission, while other circuits – notably the Ninth Circuit and Third Circuit – have disagreed.

In Macquarie, the Court had little trouble concluding that the Second Circuit had gone too far in expanding the scope of potential securities fraud liability.  The Court clarified that “Rule 10b-5(b) does not proscribe pure omissions.”  Instead, it prohibits only affirmative misstatements and the omission of materials facts necessary to ensure that statements are not misleading (i.e., “half-truths”).  The failure to provide required information under Item 303 is not a half-truth, but instead is a pure omission of information.  Had Congress or the SEC wanted to make pure omissions a basis for liability under Section 10(b) or Rule 10b-5, the Court noted, they knew how to do so because that type of liability exists under Section 11 of the Securities Act for misstatements in registration statements.

Holding: Judgment vacated and case remanded for further proceedings consistent with opinion.

Quote of note:  “[T]he difference between an omission and a half-truth is the difference between a child not telling his parents he ate a whole cake and telling them he had dessert.  Rule 10b-5(b) does not proscribe pure omissions. . . . Put differently, it requires disclosure of information necessary to ensure that that statements already made are clear and complete (i.e., that the dessert was, in fact, a whole cake.)”

Disclosure:  The author of The 10b-5 Daily participated in an amicus brief in support of Macquarie filed by the Washington Legal Foundation.

Leave a comment

Filed under Appellate Monitor, Uncategorized

Compare and Contrast

NERA Economic Consulting and Cornerstone Research have released their respective 2023 annual reports on federal securities class action filings.  As usual, the different methodologies employed by the two organizations have led to slightly different numbers, although they both identify the same general trends.

The findings for 2023 include:

(1) The reports agree that there was a slight increase in overall filings. NERA finds that there were 228 filings (compared with 206 filings in 2022), while Cornerstone finds that there were 215 filings (compared with 208 filings in 2022). Although the overall numbers remain steady, both NERA and Cornerstone note that filings involving only Section 10(b)/Rule 10b-5 claims for securities fraud are an increasing percentage of the overall filings. For example, NERA found that 184 of the 228 filings fit this description, an increase of 34% from 2022.

(2) The number of M&A filings, filings alleging Section 11 claims for misstatements in registration statements, and state 1933 Act filings continues to drop. NERA found that there were only seven merger-objection suits in 2023, a ten-year low. Cornerstone found that the number of federal Section 11 and state 1933 Act filings decreased from 50 filings in 2022 to 19 filings in 2023 (a 62% decline).

(3) According to Cornerstone, the Ninth Circuit was the busiest circuit for core filings in 2023 with 67 new filings (32% of the national total). Core filings exclude M&A filings.

(4) NERA found that when excluding settlements of $1 billion or higher, the average settlement value was $34 million in 2023, a decrease of 12% from the $39 million inflation-adjusted amount in 2022. There was an aggregate settlement value of $3.9 billion and plaintiffs’ attorneys’ fees and expenses comprised 24.9% of that number.

The NERA report can be found here. The Cornerstone report can be found here.

Leave a comment

Filed under Lies, Damn Lies, And Statistics, Uncategorized

Opting Out

Cornerstone Research has issued an interesting report on opt-outs in securities class action settlements (i.e., when a putative class member chooses not to participate in the settlement and may consider bringing its own direct action against the defendants). A few highlights from the results:

(1) The percentage of securities class action settlements with at least one opt-out has been steadily increasing, although it remains relatively small. The report concludes that from 1996 to 2005 the rate of opt-outs was 2.9%. From 2006 to 2018 the rate increased to 5.8%, and then has jumped from 2019 to H1 2022 to 11.5%.

(2) Opt-outs are more common in large securities class action settlements. The report determines that for the 2019 to H1 2022 period, opt-outs occurred in 29% of all settlements above $20 million and 62.5% of all settlements above $100 million.

(3) If institutional investors choose to opt-out, they are likely to bring their own direct actions. The report finds that from 2019 to H1 2022, there were 11 securities class action settlements where institutional investors chose to opt out (out of 287 total settlements) and in 10 of those instances at least one direct action was brought.

Leave a comment

Filed under Lies, Damn Lies, And Statistics, Uncategorized